These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17038812)

  • 21. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome.
    Ohka S; Matsuda N; Tohyama K; Oda T; Morikawa M; Kuge S; Nomoto A
    J Virol; 2004 Jul; 78(13):7186-98. PubMed ID: 15194795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.
    Nagata N; Iwasaki T; Ami Y; Harashima A; Hatano I; Suzaki Y; Yoshii K; Yoshii T; Nomoto A; Kurata T
    Vaccine; 2001 Apr; 19(23-24):3201-8. PubMed ID: 11312016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system.
    Couderc T; Girard S; Pelletier I; Gosselin AS; Destombes J; Thiesson D; Colbère-Garapin F; Blondel B
    Dev Biol (Basel); 2001; 105():225-30. PubMed ID: 11763332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.
    Ida-Hosonuma M; Iwasaki T; Yoshikawa T; Nagata N; Sato Y; Sata T; Yoneyama M; Fujita T; Taya C; Yonekawa H; Koike S
    J Virol; 2005 Apr; 79(7):4460-9. PubMed ID: 15767446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-dependent poliovirus replication in the mouse central nervous system is determined by internal ribosome entry site-mediated translation.
    Kauder S; Kan S; Racaniello VR
    J Virol; 2006 Mar; 80(6):2589-95. PubMed ID: 16501069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Random selection: a model for poliovirus infection of the central nervous system.
    Georgescu MM; Balanant J; Ozden S; Crainic R
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple pathways for establishment of poliovirus infection.
    Arita M; Ohka S; Sasaki Y; Nomoto A
    Virus Res; 1999 Aug; 62(2):97-105. PubMed ID: 10507320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic mice susceptible to poliovirus.
    Koike S; Taya C; Kurata T; Abe S; Ise I; Yonekawa H; Nomoto A
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):951-5. PubMed ID: 1846972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor.
    Yanagiya A; Jia Q; Ohka S; Horie H; Nomoto A
    J Virol; 2005 Feb; 79(3):1523-32. PubMed ID: 15650178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathogenesis of neural lesions induced by poliovirus type 1.
    Couderc T; Christodoulou C; Kopecka H; Marsden S; Taffs LF; Crainic R; Horaud F
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2907-18. PubMed ID: 2555432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poliovirus biology and pathogenesis.
    Racaniello VR; Ren R
    Curr Top Microbiol Immunol; 1996; 206():305-25. PubMed ID: 8608722
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular mechanism of tissue-specific infection of poliovirus].
    Koike S
    Uirusu; 2004 Dec; 54(2):205-12. PubMed ID: 15745158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
    Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
    J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the interrelationship between the blood-brain barrier and entry of viruses into the central nervous system. I. The effect of carbon dioxide on type II poliovirus infection in mice.
    SELLERS MI; LAVENDER JF
    J Exp Med; 1962 Jan; 115(1):107-30. PubMed ID: 13910469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.
    Gosselin AS; Simonin Y; Guivel-Benhassine F; Rincheval V; Vayssière JL; Mignotte B; Colbère-Garapin F; Couderc T; Blondel B
    J Virol; 2003 Jan; 77(1):790-8. PubMed ID: 12477887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.